CFLAR and breast cancer: To investigate whether cFLIP was capable of regulating the Wnt pathway in breast cancer cells, the protein levels of beta-catenin were determined following cFLIP inhibition by siRNA in TRAIL-sensitive MDA-MB-231 and TRAIL-resistant MCF-7 cells.